Intravenously Administered Human Umbilical Cord-Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance following Infarction via Immune Modulation

Figure 6

Schematic diagram. Iv-administered HucMSC attenuated cardiac function deterioration after infarction via systemic and local immune modulatory effects.